[老年人的正静性低血压]
Sophie Soupart1, Oswald Ayewubo1, Katharine Di Silvestro1
1Service de médecine interne de l'âgé, Département de réadaptation et gériatrie, Hôpitaux universitaires de Genève, Hôpital des Trois-Chêne, 1226 Thônex.
Revue medicale suisse
|October 30, 2025
概括
静止性低血压是老年人常见的问题,涉及到站立时血压下降. 早期诊断和管理是改善老年患者生活质量的关键.
科学领域:
- 老年病的医生 老年病的医生
- 心脏病学 心脏病学
- 神经学 神经学
背景情况:
- 静止性低血压是老年人群中普遍存在且经常被忽视的疾病.
- 它的特点是,在假设直立姿势时,血压显著下降.
- 跌倒,头,昏迷和混乱等症状是常见的表现.
研究的目的:
- 突出识别和管理老年患者正静性低血压的重要性.
- 概述这个人口群体中静止性低血压的多因素原因.
- 强调治疗的目标,包括降低发病率和死亡率,提高生活质量.
主要方法:
- 对导致正静性低血压的潜在病因因素的全面评估.
- 实施非药物和有针对性的药物治疗策略.
- 评估与发病率,死亡率和生活质量相关的患者结果.
主要成果:
- 静止性低血压在老年人中很常见,经常表现出各种症状.
- 原因是多因素的,包括衰老,药物,脱水和神经疾病.
- 综合管理方法对于有效的患者护理至关重要.
结论:
- 在老年人中有效管理正静性低血压需要对其原因进行彻底评估.
- 需要结合非药理和药理干预措施.
- 最终目标是改善患者的治疗结果和整体幸福感.
相关概念视频
Alterations in Blood Pressure
1.9K
Alterations in blood pressure, such as hypertension (high blood pressure) and hypotension (low blood pressure), significantly affect human health. Understanding these conditions' classifications, causes, and symptoms is essential for effective management and treatment.
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
1.9K
Drug Dosing: Geriatric Patients
217
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
217
Pharmacodynamics in Geriatric Patients: Effects of Age
182
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
182
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
224
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
224
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
229
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
229
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
192
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
192


